You are here
- Home
- Total number of clinical trials
An Open-label, fixed-sequence, 3-period, 3-treatment, Crossover Study to Assess the Effects of Rifampin on Pharmacokinetics of NKTR-118 in Healthy Subjects.
- Disease
- pharmacokinetics
- Drug Name
- AstraZeneca Neuroscience Development Drugs
- Generic Name
- NKTR-118
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D3820C00015
- Study Id
- D3820C00015
- ClinicalTrials.gov ID
- NCT01533870
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
